Delta-9-Tetrahydrocannabinol and Catalepsy-Like Immobilization

研究成果: 著書/レポートタイプへの貢献

1 引用 (Scopus)

抄録

The present article introduces studies related to catalepsy-like immobilization induced by delta-9-tetrahydrocannabinol (THC), the major psychoactive component of marijuana. THC induces catalepsy-like immobilization, and this behavior is antagonized by the cannabinoid (CB)1 receptor antagonist rimonabant. Also, the microinjection of THC into the nucleus accumbens induces catalepsy-like immobilization, and THC-induced catalepsy-like immobilization is prevented by lesions in the nucleus accumbens. 5-Hydroxytryptamine (5-HT) receptor agonists inhibit THC-induced catalepsy-like immobilization. In contrast, 5-HT receptor antagonists enhance THC-induced catalepsy-like immobilization. THC-induced catalepsy-like immobilization is also prevented by MK-801 and amantadine. THC decreased extracellular 5-HT levels in rat nucleus accumbens, and this effect was antagonized by rimonabant. Moreover, MK-801 abolished this THC-induced decrease in 5-HT releases. Taken together, these results demonstrate that CB1-mediated, THC-induced catalepsy-like immobilization is mediated by decreased 5-HT neurotransmission in the nucleus accumbens, due to the action of glutamate-containing neurons.

元の言語英語
ホスト出版物のタイトルHandbook of Cannabis and Related Pathologies
ホスト出版物のサブタイトルBiology, Pharmacology, Diagnosis, and Treatment
出版者Elsevier Inc.
ページ326-334
ページ数9
ISBN(電子版)9780128008270
ISBN(印刷物)9780128007563
DOI
出版物ステータス出版済み - 1 24 2017

Fingerprint

Catalepsy
Dronabinol
Immobilization
rimonabant
Nucleus Accumbens
Serotonin
Dizocilpine Maleate
Serotonin Receptors
Cannabinoid Receptor Antagonists
Amantadine
Serotonin Receptor Agonists
Serotonin Antagonists
Microinjections
Cannabis
Synaptic Transmission
Glutamic Acid

All Science Journal Classification (ASJC) codes

  • Medicine(all)
  • Neuroscience(all)

これを引用

Egashira, N. (2017). Delta-9-Tetrahydrocannabinol and Catalepsy-Like Immobilization. : Handbook of Cannabis and Related Pathologies: Biology, Pharmacology, Diagnosis, and Treatment (pp. 326-334). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-800756-3.00038-7

Delta-9-Tetrahydrocannabinol and Catalepsy-Like Immobilization. / Egashira, Nobuaki.

Handbook of Cannabis and Related Pathologies: Biology, Pharmacology, Diagnosis, and Treatment. Elsevier Inc., 2017. p. 326-334.

研究成果: 著書/レポートタイプへの貢献

Egashira, N 2017, Delta-9-Tetrahydrocannabinol and Catalepsy-Like Immobilization. : Handbook of Cannabis and Related Pathologies: Biology, Pharmacology, Diagnosis, and Treatment. Elsevier Inc., pp. 326-334. https://doi.org/10.1016/B978-0-12-800756-3.00038-7
Egashira N. Delta-9-Tetrahydrocannabinol and Catalepsy-Like Immobilization. : Handbook of Cannabis and Related Pathologies: Biology, Pharmacology, Diagnosis, and Treatment. Elsevier Inc. 2017. p. 326-334 https://doi.org/10.1016/B978-0-12-800756-3.00038-7
Egashira, Nobuaki. / Delta-9-Tetrahydrocannabinol and Catalepsy-Like Immobilization. Handbook of Cannabis and Related Pathologies: Biology, Pharmacology, Diagnosis, and Treatment. Elsevier Inc., 2017. pp. 326-334
@inbook{3c1d592a50814bc8bb85c5bc38452443,
title = "Delta-9-Tetrahydrocannabinol and Catalepsy-Like Immobilization",
abstract = "The present article introduces studies related to catalepsy-like immobilization induced by delta-9-tetrahydrocannabinol (THC), the major psychoactive component of marijuana. THC induces catalepsy-like immobilization, and this behavior is antagonized by the cannabinoid (CB)1 receptor antagonist rimonabant. Also, the microinjection of THC into the nucleus accumbens induces catalepsy-like immobilization, and THC-induced catalepsy-like immobilization is prevented by lesions in the nucleus accumbens. 5-Hydroxytryptamine (5-HT) receptor agonists inhibit THC-induced catalepsy-like immobilization. In contrast, 5-HT receptor antagonists enhance THC-induced catalepsy-like immobilization. THC-induced catalepsy-like immobilization is also prevented by MK-801 and amantadine. THC decreased extracellular 5-HT levels in rat nucleus accumbens, and this effect was antagonized by rimonabant. Moreover, MK-801 abolished this THC-induced decrease in 5-HT releases. Taken together, these results demonstrate that CB1-mediated, THC-induced catalepsy-like immobilization is mediated by decreased 5-HT neurotransmission in the nucleus accumbens, due to the action of glutamate-containing neurons.",
author = "Nobuaki Egashira",
year = "2017",
month = "1",
day = "24",
doi = "10.1016/B978-0-12-800756-3.00038-7",
language = "English",
isbn = "9780128007563",
pages = "326--334",
booktitle = "Handbook of Cannabis and Related Pathologies",
publisher = "Elsevier Inc.",
address = "United States",

}

TY - CHAP

T1 - Delta-9-Tetrahydrocannabinol and Catalepsy-Like Immobilization

AU - Egashira, Nobuaki

PY - 2017/1/24

Y1 - 2017/1/24

N2 - The present article introduces studies related to catalepsy-like immobilization induced by delta-9-tetrahydrocannabinol (THC), the major psychoactive component of marijuana. THC induces catalepsy-like immobilization, and this behavior is antagonized by the cannabinoid (CB)1 receptor antagonist rimonabant. Also, the microinjection of THC into the nucleus accumbens induces catalepsy-like immobilization, and THC-induced catalepsy-like immobilization is prevented by lesions in the nucleus accumbens. 5-Hydroxytryptamine (5-HT) receptor agonists inhibit THC-induced catalepsy-like immobilization. In contrast, 5-HT receptor antagonists enhance THC-induced catalepsy-like immobilization. THC-induced catalepsy-like immobilization is also prevented by MK-801 and amantadine. THC decreased extracellular 5-HT levels in rat nucleus accumbens, and this effect was antagonized by rimonabant. Moreover, MK-801 abolished this THC-induced decrease in 5-HT releases. Taken together, these results demonstrate that CB1-mediated, THC-induced catalepsy-like immobilization is mediated by decreased 5-HT neurotransmission in the nucleus accumbens, due to the action of glutamate-containing neurons.

AB - The present article introduces studies related to catalepsy-like immobilization induced by delta-9-tetrahydrocannabinol (THC), the major psychoactive component of marijuana. THC induces catalepsy-like immobilization, and this behavior is antagonized by the cannabinoid (CB)1 receptor antagonist rimonabant. Also, the microinjection of THC into the nucleus accumbens induces catalepsy-like immobilization, and THC-induced catalepsy-like immobilization is prevented by lesions in the nucleus accumbens. 5-Hydroxytryptamine (5-HT) receptor agonists inhibit THC-induced catalepsy-like immobilization. In contrast, 5-HT receptor antagonists enhance THC-induced catalepsy-like immobilization. THC-induced catalepsy-like immobilization is also prevented by MK-801 and amantadine. THC decreased extracellular 5-HT levels in rat nucleus accumbens, and this effect was antagonized by rimonabant. Moreover, MK-801 abolished this THC-induced decrease in 5-HT releases. Taken together, these results demonstrate that CB1-mediated, THC-induced catalepsy-like immobilization is mediated by decreased 5-HT neurotransmission in the nucleus accumbens, due to the action of glutamate-containing neurons.

UR - http://www.scopus.com/inward/record.url?scp=85019295932&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019295932&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-800756-3.00038-7

DO - 10.1016/B978-0-12-800756-3.00038-7

M3 - Chapter

AN - SCOPUS:85019295932

SN - 9780128007563

SP - 326

EP - 334

BT - Handbook of Cannabis and Related Pathologies

PB - Elsevier Inc.

ER -